RECRUITING

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance patient skills related to management of cancer treatment. Offering a patient navigation program may increase health equity and improve social needs and quality of life over time for newly diagnosed breast cancer patients.

Official Title

Addressing Disparities in Breast Cancer Care: An Approach to Health Equity

Quick Facts

Study Start:2024-11-15
Study Completion:2026-11-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06350500

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18 years of age
  2. * Have a confirmed diagnosis of breast cancer or DCIS
  3. * Have not had a previous diagnosis of cancer
  4. * Currently identify their gender as woman or female
  5. * Was assigned female sex at birth (AFAB)
  6. * Participant must understand the investigational nature of this study and verbally consent to participate prior to receiving any study related intervention
  1. * Participants under the age of 18
  2. * Participants who are not suspected of or diagnosed with breast cancer or DCIS
  3. * Participants who have had a previous diagnosis of any cancer
  4. * Participants who identify their gender as other than woman or female
  5. * Participants who were assigned male sex or intersex at birth
  6. * Unwilling or unable to follow protocol requirements

Contacts and Locations

Study Contact

Kathryn Glaser
CONTACT
716-845-7637
Kathryn.Glaser@roswellpark.org

Principal Investigator

Kathryn Glaser
PRINCIPAL_INVESTIGATOR
Roswell Park Comprehensive Cancer Center

Study Locations (Sites)

Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263
United States

Collaborators and Investigators

Sponsor: Roswell Park Cancer Institute

  • Kathryn Glaser, PRINCIPAL_INVESTIGATOR, Roswell Park Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-15
Study Completion Date2026-11-01

Study Record Updates

Study Start Date2024-11-15
Study Completion Date2026-11-01

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Carcinoma
  • Breast Ductal Carcinoma in Situ